For instance, microbes have recently been shown to drive pancreatic cancer initiation and progression in pre-clinical models by creating an immunosuppressive tumor microenvironment through increased MDSC recruitment and suppression of Th1 immune response (53) as well as stimulating IL-17 secretion (28). The gene discussed is IL17A; the disease is pancreatic neoplasm.